Università Campus Biomedico di Roma

Rome 128

1 studies enrolling now · 6 studies all time

What they study most

Arthritis, Psoriatic, Carcinoma, Ovarian Epithelial, Fallopian Tube Adenocarcinoma, Fallopian Tube Neoplasms, Fallopian Tube Serous Adenocarcinoma, Gastrointestinal Stromal Tumors, Locally Advanced or Metastatic Unresectable Urothelial Cancer, Mild Thrombocytopenia, Moderate Thrombocytopenia, Myelofibrosis, Ovarian Cancer, Ovarian Neoplasms

Studies at this site

• A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia — Recruiting now
• A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis — Completed
• Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Completed
• Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery — Running, not enrolling
• A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib — Running, not enrolling
• Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies — Completed